title: Current developments of oral retinoid therapy with three generations of drugs. Non-aromatic, monoaromatic and polyaromatic retinoids (arotinoids).
authors.forename: C E
authors.initials: CE
authors.lastname: Orfanos
authors.forename: R
authors.initials: R
authors.lastname: Stadler
authors.forename: H
authors.initials: H
authors.lastname: Gollnick
authors.forename: D
authors.initials: D
authors.lastname: Tsambaos
mesh_terms: D017255:Acitretin; D000284:Administration, Oral; D001565:Benzoates / Q000008:administration & dosage; D004485:Eczema / Q000188:drug therapy; D005050:Etretinate / Q000008:administration & dosage; D006801:Humans; D015474:Isotretinoin; D011565:Psoriasis / Q000188:drug therapy; D012176:Retinoids / Q000008:administration & dosage*; D012871:Skin Diseases / Q000188:drug therapy*; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy; D014212:Tretinoin / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D001565:Benzoates; D012176:Retinoids; D014212:Tretinoin; D005050:Etretinate; C034814:ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid; D015474:Isotretinoin; D017255:Acitretin